Skip to main content
Global Health & Medicine logoLink to Global Health & Medicine
letter
. 2023 Oct 31;5(5):316–318. doi: 10.35772/ghm.2023.01066

Advanced age - a critical risk factor for recurrent miscarriage

Hongmei Sun 1,2,3,4,§, Youhui Lu 1,2,3,§, Qing Qi 1,2,3, Meiling Li 5, Jing Zhou 1,2,3, Jing Wang 1,2,3, Jing Lin 1,2,3, Liwen Cao 6, Yan Du 1,2,7, Lisha Li 1,2,3, Ling Wang 1,2,3,*
PMCID: PMC10615023  PMID: 37908515

Summary

Recurrent spontaneous abortion (RSA) is a multifactorial disease that seriously affects womens physical and mental health. With the advent of efficient contraception, the trend for women towards later maternity until their thirties or even forties. Nevertheless, the risk of miscarriage is strongly related to maternal age. We performed a retrospective analysis to evaluate the etiology of RSA through age groups. The results demonstrated that intrauterine adhesions and ovarian dysfunction were responsible for increased miscarriages in older RSA patients. In conclusion, older women will bear a higher risk of miscarriage, mainly due to uterine adhesions or decreased ovarian function.

Keywords: maternal age, recurrent spontaneous abortion, etiology, outcome of pregnancy


Recurrent spontaneous abortion (RSA) is a multifactorial disease that seriously affects women's physical and mental health (1). The average population of women with one pregnancy loss is 10.8%, among which approximately 1.9% have experienced two consecutive miscarriages, and 0.7% have gone through three or more (2). Different national guidelines have different definitions of RSA in terms of the number of abortions, gestational age, and continuity of abortions (2-4). The Chinese expert consensus released in 2022 defined RSA as the loss of two or more failed clinical pregnancies before 28 weeks with the same sexual partner and pointed out that the occurrence of two consecutive abortions should be paid attention to and evaluated (4).

Nowadays, with the advent of efficient contraception, the trend for women towards later maternity until their thirties or even forties (5); however, the risk of miscarriage depends on the defined upper maternal age (6). The risk rises nearly linearly after age 30 to reach 54% at ages 45 and over, along with decreased egg quality and quantity sharply and an increased rate of mitochondrial DNA mutation and meiosis error (6). What's more, the rate of embryo chromosome abnormality in older women is much higher than in women of appropriate age (7). Due to the relatively high incidence rate of miscarriage, advanced maternal age has become one of the significant challenges for reproductive medicine. Here, we also designed a retrospective study to evaluate the etiology of RSA based on age grouping, which will benefit pregnant women at an advanced age.

The retrospective study includes 387 RSA patients, which were categorized into two groups depending on age: An older group (≥ 35 years older, n = 83) and a younger group (< 35 years older, n = 304). There was no significant difference in the body mass index (BMI) and the number of miscarriages between the two groups (p > 0.05) (Supplemental Table S1, https://www.globalhealthmedicine.com/site/supplementaldata.html?ID=69). Our results demonstrated that the older RSA patients had a higher incidence of intrauterine adhesions (IUA) and ovarian dysfunction than the younger counterparts (p < 0.05) due to aging and intrauterine surgery (Table 1), consistent with a previous study (8,9). IUA, a common gynecological and reproductive function uterine disease, strongly influences women's health, becoming one of the leading causes of menstrual loss, abortion, and secondary infertility. All IUA patients are high-risk pregnancies, which is associated with uterine deformation, volume reduction, or insufficient endometrial blood supply caused by IUA, easily leading to post-pregnancy abortion (10). Furthermore, the risk of IUA increases with the number of miscarriage procedures performed (11). There were no statistically significant differences in chromosomal abnormalities, endocrine abnormalities, autoimmune abnormalities, coagulation abnormalities, and infection factors between the two groups (Table 1). Hormone levels are significant factors affecting the success of embryo implantation and pregnancy rates. As shown in (Supplemental Table S2, https://www.globalhealthmedicine.com/site/supplementaldata.html?ID=69), the level of AMH in the older patients with three or more abortions was significantly lower than that in the older sporadic abortion group (p < 0.05), in agreement with the previous result that a low AMH level is associated with high abortion rates in women older than 34 years old (12).

Table 1. The detailed comparison of RSA causes in the different age groups.

Causes of RSA Aged < 35 (n = 304) Aged ≥ 35 (n = 83) p value
Chromosome (%) 11 (3.6) 4 (4.8) 0.538
Anatomy (%) 10 (3.3) 10 (12) 0.003*
    Bicornuate uterus 1 (0.3) 0 1.000
    Mediastinal uterus 4 (1.3) 2 (2.4) 0.613
    Adenomyosis 0 1 (1.2) 0.214
    Uterine fibroids 1 (0.3) 0 1.000
    Intrauterine adhesions 3 (1.0) 6 (7.2) 0.004*
    Cervical insufficiency 1 (0.3) 1 (1.2) 0.383
Endocrine (%) 71 (23.4) 21 (25.3) 0.771
    Hyperthyroidism 5 (1.6) 2 (2.4) 0.646
    Hypothyroidism 5 (1.6) 2 (2.4) 0.646
    Subclinical hypothyroidism 27 (8.9) 7 (8.4) 0.898
    Polycystic ovary syndrome 6 (2.0) 1 (1.2) 1.000
    Decreased ovarian function 1 (0.3) 8 (9.6) 0.000*
    Impaired glucose tolerance 5 (1.6) 0 0.589
    Insulin resistance 34 (11.2) 4 (4.8) 0.097
Autoimmue (%) 74 (24.3) 23 (27.7) 0.568
    AsAb 10 (3.3) 1 (1.2) 0.469
    EMAb 9 (3.0) 3 (3.6) 0.726
    TPOAb 20 (6.6) 5 (6.0) 1.000
    TGAb 14 (4.6) 7 (8.4) 0.177
    ACA 6 (2.0) 1 (1.2) 1.000
    α-β2GP1 27 (8.9) 10 (12.0) 0.401
    ANA 11 (3.6) 4 (4.8) 0.538
Coagulation (%) 19 (6.3) 2 (2.4) 0.272
    Higher D-dimer 12 (3.9) 1 (1.2) 0.315
    Hyperhomocysteinemia 7 (2.3) 1 (1.2) 1.000
Infection (%) 35 (11.5) 5 (6.0) 0.161
Unexplained (%) 146 (48.0) 34 (41.0) 0.266

Data are n (%); RSA: recurrent spontaneous abortion; AsAb: anti-sperm antibody; EMAb: anti-endometrial antibody; TPOAb: anti-thyroid peroxidase antibody; TGAb: anti-thyroglobulinantibody; ACA: anti-cardiolipin antibodies; anti-β2GP1: anti-β2-glycoprotein 1 antibody; ANA: antinuclear antibody; *p < 0.05.

This study investigated the etiology composition of RSA based on age factors. In conclusion, intrauterine adhesions and ovarian dysfunction increased the number of abortions in older RSA patients (≥ 35 years older). More research is needed to elucidate the etiology and mechanisms for recurrent spontaneous abortion.

Funding

This work was supported by grants from a project under the Scientific and Technological Innovation Action Plan of the Shanghai Natural Science Fund (grant no. 20ZR1409100 to L Wang), a project of the Chinese Association of Integration of Traditional and Western Medicine special foundation for Obstetrics and Gynecology-PuZheng Pharmaceutical Foundation (grant no. FCK-PZ-08 to L Wang), a project for hospital management of the Shanghai Hospital Association (grant no. X2021046 to L Wang), a clinical trial project of the Special Foundation for Healthcare Research of the Shanghai Municipal Health Commission (grant no. 202150042 to L Wang), a project of Innovation Foundation of Higher Education of Gansu Province (grant no. 2021B-239 to HM Sun), a project of the Natural Science Foundation of Gansu province (grant no. 23JRRG0009 to HM Sun), and a project of the science and technology programs of Zhoushan, Zhejiang (grant no. 2021C31055 to WL Cao).

Conflict of Interest

The authors have no conflicts of interest to disclose.

References

  • 1. Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: A committee opinion. Fertil Steril. 2020; 113:533-535. [DOI] [PubMed] [Google Scholar]
  • 2. Quenby S, Gallos ID, Dhillon-Smith RK, et al. Miscarriage matters: The epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet. 2021; 397:1658-1667. [DOI] [PubMed] [Google Scholar]
  • 3. ESHRE Guideline Group on RPL, Bender Atik R, Christiansen OB, Elson J, Kolte AM, Lewis S, Middeldorp S, Nelen W, Peramo B, Quenby S, Vermeulen N, Goddijn M. ESHRE guideline: Recurrent pregnancy loss. Hum Reprod Open. 2018; 2018:hoy004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association, Chinese Expert Consensus Group on Diagnosis and Management of Recurrent Spontaneous Abortion. Chinese expert consensus on diagnosis and management of recurrent spontaneous abortion (2022). Zhonghua Fu Chan Ke Za Zhi. 2022; 57:653-667. (in Chinese) [DOI] [PubMed] [Google Scholar]
  • 5. Bedenk J, Vrtačnik-Bokal E, Virant-Klun I. The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility. J Assist Reprod Genet. 2020; 37:89-100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE. Role of maternal age and pregnancy history in risk of miscarriage: Prospective register based study. BMJ. 2019; 364:l869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Huang Y, Tu M, Qian Y, et al. Age-dependent metabolomic profile of the follicular fluids from women undergoing assisted reproductive technology treatment. Front Endocrinol (Lausanne). 2022; 13:818888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Bunnewell SJ, Honess ER, Karia AM, Keay SD, Al Wattar BH, Quenby S. Diminished ovarian reserve in recurrent pregnancy loss: A systematic review and meta-analysis. Fertil Steril. 2020; 113:818-827. [DOI] [PubMed] [Google Scholar]
  • 9. Carbonnel M, Pirtea P, de Ziegler D, Ayoubi JM. Uterine factors in recurrent pregnancy losses. Fertil Steril. 2021; 115:538-545. [DOI] [PubMed] [Google Scholar]
  • 10. Li B, Zhang Q, Sun J, Lai D. Human amniotic epithelial cells improve fertility in an intrauterine adhesion mouse model. Stem Cell Res Ther. 2019; 10:257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Hooker AB, de Leeuw RA, Emanuel MH, Mijatovic V, Brolmann HAM, Huirne JAF. The link between intrauterine adhesions and impaired reproductive performance: A systematic review of the literature. BMC Pregnancy Childbirth. 2022; 22:837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Zarek SM, Mitchell EM, Sjaarda LA, Mumford SL, Silver RM, Stanford JB, Galai N, Schliep KC, Radin RG, Plowden TC, DeCherney AH, Schisterman EF. Antimüllerian hormone and pregnancy loss from the effects of aspirin in gestation and reproduction trial. Fertil Steril. 2016; 105:946-952. e942 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Global Health & Medicine are provided here courtesy of National Center for Global Health and Medicine, Japan

RESOURCES